Table 4.
Logistic regression model identifying patient related factors associated with COVID-19 positive patients and a hip fracture.
| Demographic | Descriptive | Odds Ratio (95% CI) | p-value∗ |
|---|---|---|---|
| Age (for each increasing year) | 1.00 (0.99–1.02) | 0.428 | |
| Sex | Female | Reference | |
| Male | 1.38 (1.13–1.69) | 0.001 | |
| Nottingham Hip Score (for each increasing point) | 1.03 (0.99–1.06) | 0.129 | |
| Residence | Home/Sheltered | Reference | |
| Care/Nursing home | 2.15 (1.69–2.73) | <0.001 | |
| Hospital | 1.31 (0.63–2.72) | 0.467 | |
| Missing | 2.57 (1.73–3.83) | <0.001 | |
| Place of injury | Home/Indoor | Reference | |
| Outdoor | 0.58 (0.40–0.84) | 0.004 | |
| Hospital | 2.23 (1.31–3.79) | 0.003 | |
| Missing | 1.22 (0.74–2.01) | 0.436 | |
| Comorbidity∗ | Not present | ||
| CVD | 1.24 (0.99–1.53) | 0.051 | |
| Renal Disease | 0.85 (0.68–1.07) | 0.165 | |
| Pulmonary Disease | 0.99 (0.79–1.23) | 0.917 | |
| Dementia | 1.18 (0.94–1.48) | 0.164 | |
| Cancer | 0.63 (0.44–0.89) | 0.009 | |
| ASA grade | 1 | 0.69 (0.21–2.31) | 0.548 |
| 2 | Reference | ||
| 3 | 1.16 (0.85–1.57) | 0.352 | |
| 4 | 1.59 (1.13–2.25) | 0.008 | |
| 5 | 8.28 (2.81–24.42) | <0.001 | |
| Missing or N/A | 0.68 (0.36–1.30) | 0.246 | |
| Admission Blood tests (for each point) | Lymphocyte Count (x 109/L) | 0.83 (0.71–0.98) | 0.023 |
| Albumin Concentration (g/L) | 0.99 (0.97–1.00) | 0.102 | |
| Length of stay (for each increasing day) | 1.06 (1.05–1.07) | <0.001 | |